Fortunately, there are effective ways to manage GLP-1-related constipation, including support from pelvic floor physical therapy
GLP-1 drugs have been linked to several eye problems, including: Non-arteritic anterior ischemic optic neuropathy (NAION) Optic neuropathy Retinal ischemia Exacerbation of diabetic retinopathy These GLP-1 eye problems can range from mild visual field defects to complete blindness in one eye
The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis
So, we don't expect a big increase in longer term interest rates
Ideal for use during recovery, illness, stress, or nutritional support
Pending regulatory approvals, oral semaglutide has the potential to be the first and only oral GLP-1 RA to demonstrate superior glycemic efficacy versus placebo in children and adolescents with type 2 diabetes, while maintaining the well-established safety profile seen across the semaglutide portfolio.